To include your compound in the COVID-19 Resource Center, submit it here.

Aeterna Zentaris, Orient Europharma deal

Aeterna granted Orient’s Cyntec Co. Ltd. affiliate exclusive rights to develop and

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE